BR112018013168A2 - vírus mutantes, método de preparação e uso dos mesmos - Google Patents

vírus mutantes, método de preparação e uso dos mesmos

Info

Publication number
BR112018013168A2
BR112018013168A2 BR112018013168-7A BR112018013168A BR112018013168A2 BR 112018013168 A2 BR112018013168 A2 BR 112018013168A2 BR 112018013168 A BR112018013168 A BR 112018013168A BR 112018013168 A2 BR112018013168 A2 BR 112018013168A2
Authority
BR
Brazil
Prior art keywords
virus
present
relates
mutant
preparation
Prior art date
Application number
BR112018013168-7A
Other languages
English (en)
Portuguese (pt)
Chinese (zh)
Inventor
Zhou Demin
Si Longlong
Zhou Xueying
Zhang Ziwei
Xu Huan
Tian Zhenyu
Zhang Chuanling
Xiao Sulong
Xia Qing
Zhang Lihe
Original Assignee
Peking University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University filed Critical Peking University
Publication of BR112018013168A2 publication Critical patent/BR112018013168A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01026—Pyrrolysine-tRNAPyl ligase (6.1.1.26)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR112018013168-7A 2015-12-31 2016-08-02 vírus mutantes, método de preparação e uso dos mesmos BR112018013168A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201511029463.1 2015-12-31
CN201511029463.1A CN106929482A (zh) 2015-12-31 2015-12-31 定点突变的流感病毒、其活疫苗及其制备方法和应用
PCT/CN2016/092778 WO2017113786A1 (zh) 2015-12-31 2016-08-02 突变的病毒、其制备方法和应用

Publications (1)

Publication Number Publication Date
BR112018013168A2 true BR112018013168A2 (pt) 2018-12-11

Family

ID=59224413

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018013168-7A BR112018013168A2 (pt) 2015-12-31 2016-08-02 vírus mutantes, método de preparação e uso dos mesmos

Country Status (11)

Country Link
US (1) US11510974B2 (https=)
EP (1) EP3399029A4 (https=)
JP (1) JP2019500051A (https=)
CN (2) CN106929482A (https=)
AU (1) AU2016383201A1 (https=)
BR (1) BR112018013168A2 (https=)
CA (1) CA3010015A1 (https=)
CO (1) CO2018006706A2 (https=)
IL (1) IL260258A (https=)
WO (1) WO2017113786A1 (https=)
ZA (1) ZA201804362B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112725282A (zh) * 2016-01-27 2021-04-30 北京大学 携带正交tRNA/氨酰tRNA合成酶的稳定细胞系的构建
CN109295100A (zh) * 2017-07-25 2019-02-01 北京大学 携带正交tRNA/氨酰tRNA合成酶的稳定细胞系的构建
CN107964035B (zh) * 2017-12-06 2020-07-24 中国科学院微生物研究所 一种用于流感病毒的有限复制型黏膜免疫疫苗
CN109180680B (zh) * 2018-08-01 2020-05-08 苏州大学 一种紫外光触发交联型近红外分子探针及其制备方法与应用
CN110835633B (zh) * 2018-08-13 2021-10-01 北京大学 利用优化的基因密码子扩展系统制备ptc稳定细胞系及应用
CN110846311A (zh) * 2018-08-20 2020-02-28 北京大学 利用抑制性tRNA系统制备PTC稳定细胞系及应用
CN109111508B (zh) * 2018-09-19 2021-03-19 天康生物股份有限公司 禽流感病毒血凝素抗原及表达其的cho细胞株、制备方法和疫苗
CN109652384B (zh) * 2019-02-21 2021-10-26 昆明理工大学 一种体外培养戊型肝炎病毒的方法
CN109957550B (zh) * 2019-03-13 2020-10-20 浙江森卫生物医药发展有限公司 流感病毒的拯救方法及其组合物
CN109943536B (zh) * 2019-03-26 2021-09-14 昆明理工大学 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法
CN110042084A (zh) * 2019-04-11 2019-07-23 浙江森卫生物医药发展有限公司 一种活病毒流感疫苗的生产方法以及制剂
CN109971888A (zh) * 2019-04-11 2019-07-05 浙江森卫生物医药发展有限公司 一种复制可控型流感病毒的检测方法
WO2021004389A1 (zh) * 2019-07-05 2021-01-14 司龙龙 蛋白水解靶向病毒、其活疫苗及其制备方法和用途
CN110743007B (zh) * 2019-09-10 2023-05-30 安徽智飞龙科马生物制药有限公司 一种联合疫苗及其制备方法、应用
CN110845587B (zh) 2019-10-15 2021-06-29 康希诺生物股份公司 一种定点突变的载体蛋白及其在制备疫苗中的用途
CN111533792B (zh) * 2020-07-07 2020-10-16 康希诺生物股份公司 一种定点突变的载体蛋白及其在制备疫苗中的用途
CN113502274A (zh) * 2021-06-21 2021-10-15 武汉大学 一种表达人乳头瘤病毒衣壳蛋白l2的重组流感病毒株及其制备方法与应用
CN115074330B (zh) * 2022-04-19 2023-12-29 中国医学科学院医学生物学研究所 一种基于遗传密码子扩展技术的改造Vero细胞系
WO2024040453A1 (zh) * 2022-08-24 2024-02-29 北京大学宁波海洋药物研究院 突变的流感病毒、药物组合物及用途
CN116804187A (zh) * 2023-07-24 2023-09-26 中国农业科学院兰州兽医研究所 一种复制缺陷型口蹄疫病毒、构建方法及应用
CN116904403B (zh) * 2023-09-13 2024-01-09 北京民海生物科技有限公司 一种腮腺炎病毒突变体及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083970B2 (en) * 2001-04-19 2006-08-01 The Scripps Research Institute Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
MXPA04000589A (es) * 2001-07-20 2005-06-17 Univ Georgia Res Found Virus de la rabia atenuado con mutacion de nucleoproteina en el sitio de fosforilacion para vacunacion contra la rabia y terapia genetica en el snc.
CN101970005A (zh) * 2008-02-08 2011-02-09 斯克利普斯研究院 用遗传编码的非天然氨基酸打破免疫耐受
PE20110480A1 (es) * 2008-09-26 2011-07-01 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales
TW201125984A (en) * 2009-10-09 2011-08-01 Univ New York State Res Found Attenuated influenza viruses and vaccines
CN102838663B (zh) * 2011-06-23 2014-06-11 北京大学 定点突变和定点修饰的病毒膜蛋白、其制备方法及其应用
SG10201702387YA (en) * 2012-09-24 2017-04-27 Medimmune Ltd Cell lines
CN102964432B (zh) * 2012-11-22 2014-02-05 中国科学院微生物研究所 抑制a型流感病毒m1蛋白发生磷酸化的方法及其应用
CN104592364B (zh) * 2013-10-30 2018-05-01 北京大学 定点突变和定点修饰的腺相关病毒、其制备方法及应用
EP3087088B1 (en) * 2013-12-23 2022-05-25 University Of Rochester Methods and compositions for ribosomal synthesis of macrocyclic peptides
CA2936615C (en) * 2014-01-14 2023-06-13 European Molecular Biology Laboratory Multiple cycloaddition reactions for labeling of molecules
US10322172B2 (en) * 2014-02-10 2019-06-18 Nutech Ventures Live, attenuated vaccines and methods of making and using
MA40773A (fr) * 2014-10-02 2017-08-08 Vertex Pharma Variants du virus influenza a

Also Published As

Publication number Publication date
WO2017113786A1 (zh) 2017-07-06
JP2019500051A (ja) 2019-01-10
CN109563492A (zh) 2019-04-02
EP3399029A4 (en) 2019-07-17
US11510974B2 (en) 2022-11-29
CA3010015A1 (en) 2017-07-06
EP3399029A1 (en) 2018-11-07
AU2016383201A1 (en) 2018-07-05
CN109563492B (zh) 2023-05-12
CN106929482A (zh) 2017-07-07
US20200268870A1 (en) 2020-08-27
CO2018006706A2 (es) 2018-07-10
IL260258A (en) 2018-07-31
ZA201804362B (en) 2019-04-24

Similar Documents

Publication Publication Date Title
BR112018013168A2 (pt) vírus mutantes, método de preparação e uso dos mesmos
CY1125368T1 (el) Εμβολια κατα των ιων του αναπνευστικου συστηματος
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
BR112018008102A2 (pt) vacina de vírus sincicial respiratório
EP4691484A3 (en) Influenza mrna vaccines
CL2017000064A1 (es) Vacunas contra virus influenza y usos de las mismas
EP4218807A3 (en) Zika virus vaccine
MX2022006603A (es) Vacuna contra el virus de la influenza de amplio espectro.
MA50335A (fr) Vaccins à acide nucléique contre des virus respiratoires
CL2017000780A1 (es) Composiciones y métodos para silenciar la expresión del virus gen de la hepatitis b
AR096113A1 (es) Polipéptidos f de prefusión del virus sincicial respiratorio (rsv) solubles y estabilizados
MA41349A (fr) Éradication de l'herpès simplex de type i et d'autres virus de l'herpès associés guidée par arn
CL2017000063A1 (es) Vacunas contra virus influenza y usos de las mismas
CL2013002712A1 (es) Composicion inmunogénica para modular sistema inmune que comprende agentes con patrones asociados a bacterias, virus, hongos y levaduras, protozoos, helmintos y/o priones; uso para tratar enfermedades autoinmunes o infecciosas.
PH12015502230A1 (en) Novel viral replication inhibitors
BR112018010503A2 (pt) ovo de ave, método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, ave transgênica, e método para produzir uma ave
MX2019005102A (es) Poxvirus quimericos sinteticos.
EP3939604A3 (en) Influenza hemagglutinin protein vaccines
PH12014500369A1 (en) Influenza h5 vaccines
MX2017009812A (es) Composiciones y metodos para inhibir infeccion viral.
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
BR112016022214A2 (pt) rnase para uso no tratamento ou prevenção de infecções virais
BR112018002635A2 (pt) plantas compreendendo um baixo número de cópias de genes ri
BR112017004452A2 (pt) vírus atenuado, arbovírus atenuado, seus usos, composição de vacina, método de produção de um genoma de vírus atenuado, método de produção de um arbovírus atenuado e genoma de arbovírus atenuado
MX2022001430A (es) Formulaciones de vacuna contra chikungu?a.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2529 DE 25-06-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]